Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 105 results for "biocon"

Biosimilar progress adds to Biocon's prospects as stock gains 14%
Business Standard

Biosimilar progress adds to Biocon's prospects as stock gains 14%

Your access to The Wall Street Journal online is subject to you not being an existing user of The Wall Street Journal online. Existing users include current or past Premium Users of The Wall Street Journal online. If you happen to be one, your subscription ... Business Standard, 3 days ago

82 images for biocon

Business Standard, 3 days ago
Business Standard, 3 days ago
Money Control, 2 weeks ago
Business Standard, 1 week ago
Money Control, 2 weeks ago
Money Control, 2 weeks ago
Money Control, 2 weeks ago
Money Today, 1 month ago
Business Standard, 1 month ago
Money Control, 3 weeks ago
Business Standard

Derivative Strategy for Biocon by HDFC Securities

Derivative Strategy for Biocon by Devarsh Vakil & Nandish Shah - PCG Desk, HDFC Securities: Last Updated at February 9, 2018 07:45 IST Photo: Shutterstock.com Derivative Strategy for Biocon by Devarsh Vakil & Nandish Shah - PCG Desk, HDFC Securities: Buy ...
 Business Standard1 week ago
Money Control

Data science ushering in next wave of drug innovation: Biocon CMD

Speaking at the annual lecture on #39;strategic importance of data science in research and innovation#39;, she said leveraging advance data analytics presents a real and significant opportunity for the pharmaceutical industry.
 Money Control2 weeks ago
Money Today

Biocon shares hit 52 week high on Sandoz deal

Biocon shares surged over 5% in today's trade after it announced global partnership with Sandoz to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide. The partnership is likely to be a significant ...
 Money Today1 month ago Biocon gains 4% on global partnership with Sandoz for biosimilars in immunology, oncology  Money Control1 month ago Biocon hits record high on collaboration with Sandoz  Business Standard1 month ago Biocon shares jump nearly 6 pc on collaboration with Sandoz  Business Standard1 month ago
Sify

Biocon stocks plunge, after company reports 46 percent decline in profits

Bengaluru: Shares of pharma and biotech major, Biocon slumped after the company reported a Rs 92 crore consolidated net profit for the third quarter of 2017-18, a 46 per cent decline annually from Rs 171 crore in the same period a year ago. The stocks dipped ...
 Sify3 weeks ago Biocon tumbles after weak Q3 results  Business Standard3 weeks ago Biocon Q3 net profit plunges 46% to Rs 920 million on higher interest  Business Standard3 weeks ago Syngene Q3 net profit up 11% at Rs 82 crore  Money Control3 weeks ago
Business Standard

HSBC maintains hold on Biocon; hikes target with 67.5% upside

Recent FDA approval for Ogivri validates Biocon’s biosimilar development capabilities, HSBC said.
 Money Control1 month ago Biocon and Mylan's breast cancer biosimilar receives approval from ANVISA  Business Standard1 month ago Biocon gets shareholders' nod for transfer of biosimilars business  Business Standard2 months ago Biocon scales record high after USFDA nod for biosimilar  Business Standard2 months ago
[x]  
Money Control

Market Live: Midcap outperforms Sensex; Nifty choppy, PSU Bank index dips 2%

LT Infotech, Bharat Bijlee, Everest Industries and KEI Industries rallied post earnings. Biocon lost 4.5 percent after bad earnings.
 Money Control3 weeks ago Market Live: Nifty opens flat ahead of FO expiry; Sensex consolidates; SBI dips  Money Control3 weeks ago
Money Control

Stock market prediction for January 22-25: Satish Gupta

Pharma stocks like Granules India, Sun Pharma, Wockhardt, Ajanta Pharma, Biocon and Marksans Pharma will get astrological support, says Satish Gupta of astrostocktips.
 Money Control4 weeks ago Pharma shares gain; Sun Pharma hits seven-month high  Business Standard1 month ago
Money Control

Market Update: CNX Auto rallies as Maruti, Hero Moto jumps 4%, Jain Irrigation zooms over 10%; HUL, Biocon hit 52-week high

The market breadth was in favour of the advances on Tuesday afternoon with 1308 stocks advancing as against 383 declines while 298 remained unchanged. On the other hand, 1831 stocks advanced and 775 stocks declined while 175 remained unchanged on the BSE.
 Money Control2 months ago Market Update: Infosys, Zee gains 2-3%; Jubilant Food jumps over 5%; UPL, Coal India top losers  Money Control2 months ago Market Update: Biocon hits new 52-week high after jumping 10%; Infosys gains 3%, HDFC, SBI most active  Money Control2 months ago Market Update: SAIL jumps over 4% as midcap outperforms; Biocon, DLF hit new 52-week high; SBI most active  Money Control2 months ago

Biocon heads higher after getting positive CHMP opinion for product

after the company said that European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Semglee, insulin glargine. The announcement was made after market hours yesterday, 29 January 2018.
 Business Standard3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less